buprenorphine transdermal system
NDC 58064-408, buprenorphine, patch, extended release, from LTS Therapy Systems, LLC.
- Product NDC
- 58064-408
- Status
- Listed
- Labeler
- LTS Therapy Systems, LLC
- Dosage form
- PATCH, EXTENDED RELEASE
- Route
- TRANSDERMAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA207490
- DEA schedule
- CIII
curl https://api.healthcare.dev/v1/drugs/ndc/58064-408 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- BUPRENORPHINE20 ug/h
Pharmacologic classes
Partial Opioid Agonist [EPC]; Partial Opioid Agonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 58064-408-04 | 58064040804 | 4 POUCH in 1 CARTON (58064-408-04) / 1 PATCH in 1 POUCH (58064-408-11) / 168 h in 1 PATCH |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 58064-408 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/58064-408 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 58064-408. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.